Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

A meta-analysis of comparative studies of endovascular versus open repair for blunt thoracic aortic injury Hisato Takagi, MD, PhD, Norikazu Kawai, MD,

Stephen D. Cassivi, MD, MSc, FRCSC, FACS

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement Charles R. Bridges, MD,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

Victor van Berkel, MD, PhD

Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.

Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent? Giuseppe Santarpino, MD, Steffen.

Bicuspid aortic valve aortopathy: One size fits all?

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

The lord of the rings Antonio Miceli, MD, PhD

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

The variability of the mitral valve anatomy and terminology

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians Isaac George, MD, Halit Yerebakan, MD, Bindu.

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Torsten Doenst, MD, PhD, Markus Richter, MD

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Kevin Bridge, MD, MSPH, Robert Saeid Farivar, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

The Journal of Thoracic and Cardiovascular Surgery

Replicating the success of mitral valve repair in the aortic valve

A fate worse than death Jennifer S. Lawton, MD

The Ross procedure: Time to reevaluate the guidelines

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

The Mitroflow aortic valve: A past, present, and future illuminated

Hans-Joachim Schäfers, MD

The harder one looks, the more one finds

Concomitant replacement of the ascending aorta is free—for some

Innovation in cardiothoracic surgical training

Quality of life after aortic valve surgery: Replacement versus reconstruction Diana Aicher, MD, Annika Holz, Susanne Feldner, MD, Volker Köllner, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome Jess L. Thompson, MD, Hartzell V. Schaff,

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

Between a rock and a hard place

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland, MSc, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 132, Issue 1, Pages 20-26.e3 (July 2006) DOI: 10.1016/j.jtcvs.2006.01.043 Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Mean age (■) ± 2 standard deviations (SDs) of the 15 mechanical and 23 bioprosthetic valve series. Areas of the squares are proportional to the total follow-up (patient-y) in each valve series. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 20-26.e3DOI: (10.1016/j.jtcvs.2006.01.043) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Total death rate of the 15 mechanical (■) and 23 bioprosthetic (□) valve series in relation to mean age of each series. Areas of the squares are proportional to the total follow-up (patient-y) in each valve series. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 20-26.e3DOI: (10.1016/j.jtcvs.2006.01.043) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions